Xenon Pharmaceuticals Inc.
XENE· Nasdaq
XENEXenon Pharmaceuticals Inc.
Filed Mar 12, 2015 · 10-K · 71 days after period end · 0001564590-15-001612
| Metric | Q4 2014 | Q4 2013 |
|---|---|---|
| Revenue | $4.88M | $5.58M |
| Net Income | $1.22M | — |
| EPS Diluted | $0.13 | $1.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenon Pharmaceuticals Inc. · CIK 1582313 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 12, 2015 · 71 d after period end
